Archive: 2026/03
Ketamine and Esketamine: Rapid-Acting Options for Depression
Ketamine and esketamine offer fast relief for treatment-resistant depression, working in hours instead of weeks. Learn how they compare in effectiveness, safety, cost, and access-and which might be right for you.
How TRIPS Trade Agreements Shape Access to Generic Medicines
TRIPS trade rules control how generic medicines are made and sold worldwide. They’ve raised drug prices, blocked access in poor countries, and created legal barriers-even when life is at stake. The system favors profits over people.
Provider Cost Awareness: Do Clinicians Know Drug Prices?
Most clinicians don't know what their patients pay for prescriptions. This knowledge gap leads to poor prescribing, non-adherence, and wasted spending. Real-time cost tools are changing that - but only where they're implemented.
Melanoma: Early Detection and Immunotherapy Treatment
Melanoma survival rates jump from 32% to 99% when caught early. Learn how AI tools like SegFusion and wearable patches are revolutionizing detection - and how immunotherapy is turning metastatic melanoma into a manageable condition.
Supply Chain Economics: How Efficiency Drives Generic Drug Distribution
Efficiency in generic drug distribution isn't just about cost-it's about preventing life-threatening shortages. Learn how data, technology, and smart inventory strategies are reshaping the future of affordable medicines.